Explaining the rise of diaspora institutions by Gamlen, A, Cummings, M, Vaaler, P, Rossouw, L

The palaeoecological context of the Oldowan-Acheulean in southern Africa by Ecker, M, Brink, J, Rossouw, L, Chazan, M, Horwitz, L, Lee-Thorp, J

A new paleoecological context for the Oldowan-Acheulean in Southern Africa by Ecker, M, Brink, J, Rossouw, L, Chazan, M, Horwitz, L, Lee-Thorp, J

Plasma inflammatory biomarkers predict CD4+ T-cell recovery and viral rebound in HIV-1 infected Africans on suppressive antiretroviral therapy by Kroeze, S, Rossouw, TM, Steel, HC, Wit, FW, Kityo, CM, Siwale, M, Akanmu, S, Mandaliya, K, De Jager, M, Ondoa, P, Reiss, P, De Wit, TFR, Kootstra, NA

Plasma biomarkers of HIV-related systemic inflammation and immune activation in sub-Saharan Africa before and during suppressive antiretroviral therapy by Kroeze, S, Wit, F, Rossouw, T, Steel, H, Kityo, C, Siwale, M, Akanmu, S, Mandaliya, K, De Jager, M, Ondoa, P, Reiss, P, Rinke De Wit, T, Kootstra, N, Hamers, R

Targeted next-generation sequencing identifies novel variants in candidate genes for Parkinson’s disease in Black South African and Nigerian patients by Oluwole, OG, Kuivaniemi, H, Abrahams, S, Haylett, WL, Vorster, AA, van Heerden, CJ, Kenyon, CP, Tabb, DL, Fawale, MB, Sunmonu, TA, Ajose, A, Olaogun, MO, Rossouw, AC, van Hillegondsberg, LS, Carr, J, Ross, OA, Komolafe, MA, Tromp, G, Bardien, S

Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysi... by Madhi, SA, Kwatra, G, Richardson, SI, Koen, AL, Baillie, V, Cutland, CL, Fairlie, L, Padayachee, SD, Dheda, K, Barnabas, SL, Bhorat, QE, Briner, C, Ahmed, K, Aley, PK, Bhikha, S, Bhorat, AE, Esmail, A, Horne, E, Kaldine, H, Mukendi, CK, Madzorera, VS, Manamela, NP, Masilela, M, Hermanus, ST, Motlou, T, Mzindle, N, Oelofse, S, Patel, F, Rhead, S, Rossouw, L, Taoushanis, C, van Eck, S, Lambe, T, Gilbert, SC, Pollard, AJ, Moore, PL, Izu, A

Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B.1.351 variant by Madhi, SA, Baillie, V, Cutland, CL, Voysey, M, Koen, AL, Fairlie, L, Padayachee, SD, Dheda, K, Barnabas, SL, Bhorat, QE, Briner, C, Kwatra, G, Ahmed, K, Aley, P, Bhikha, S, Bhiman, JN, Bhorat, AE, du Plessis, J, Esmail, A, Groenewald, M, Horne, E, Hwa, S-H, Jose, A, Lambe, T, Laubscher, M, Malahleha, M, Masenya, M, Masilela, M, McKenzie, S, Molapo, K, Moultrie, A, Oelofse, S, Patel, F, Pillay, S, Rhead, S, Rodel, H, Rossouw, L, Taoushanis, C, Tegally, H, Thombrayil, A, van Eck, S, Wibmer, CK, Durham, NM, Kelly, EJ, Villafana, TL, Gilbert, S, Pollard, AJ, de Oliveira, T, Moore, PL, Sigal, A, Izu, A